152 related articles for article (PubMed ID: 22500790)
1. Relationship between pancreatic and/or extrapancreatic lesions and serum IgG and IgG4 levels in IgG4-related diseases.
Igarashi H; Ito T; Oono T; Nakamura T; Fujimori N; Niina Y; Hijioka M; Uchida M; Lee R; Iwao R; Nakamura K; Kotoh K; Takayanagi R
J Dig Dis; 2012 May; 13(5):274-9. PubMed ID: 22500790
[TBL] [Abstract][Full Text] [Related]
2. Serum IgG4 levels and extrapancreatic lesions in autoimmune pancreatitis.
Kamisawa T; Imai M; Egawa N; Tsuruta K; Okamoto A
Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1167-70. PubMed ID: 18936710
[TBL] [Abstract][Full Text] [Related]
3. Chronic sclerosing sialadenitis (Küttner tumor) is an IgG4-associated disease.
Geyer JT; Ferry JA; Harris NL; Stone JH; Zukerberg LR; Lauwers GY; Pilch BZ; Deshpande V
Am J Surg Pathol; 2010 Feb; 34(2):202-10. PubMed ID: 20061932
[TBL] [Abstract][Full Text] [Related]
4. Serum immunoglobulin G4 associated with number and distribution of extrapancreatic lesions in type 1 autoimmune pancreatitis patients.
Kaji R; Takedatsu H; Okabe Y; Ishida Y; Sugiyama G; Yonemoto K; Mitsuyama K; Tsuruta O; Sata M
J Gastroenterol Hepatol; 2012 Feb; 27(2):268-72. PubMed ID: 21929654
[TBL] [Abstract][Full Text] [Related]
5. Lymphadenopathy of IgG4-related sclerosing disease.
Cheuk W; Yuen HK; Chu SY; Chiu EK; Lam LK; Chan JK
Am J Surg Pathol; 2008 May; 32(5):671-81. PubMed ID: 18344866
[TBL] [Abstract][Full Text] [Related]
6. IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathy.
Kamisawa T; Nakajima H; Egawa N; Funata N; Tsuruta K; Okamoto A
Pancreatology; 2006; 6(1-2):132-7. PubMed ID: 16327291
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune pancreatitis: a systemic immune complex mediated disease.
Deshpande V; Chicano S; Finkelberg D; Selig MK; Mino-Kenudson M; Brugge WR; Colvin RB; Lauwers GY
Am J Surg Pathol; 2006 Dec; 30(12):1537-45. PubMed ID: 17122509
[TBL] [Abstract][Full Text] [Related]
8. IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity.
Cheuk W; Chan JK
Adv Anat Pathol; 2010 Sep; 17(5):303-32. PubMed ID: 20733352
[TBL] [Abstract][Full Text] [Related]
9. Roles of IL-17, Th1, and Tc1 cells in patients with IgG4-related sclerosing sialadenitis.
Ohta N; Makihara S; Okano M; Kurakami K; Ishida A; Furukawa T; Suzuki Y; Watanabe T; Kakehata S; Aoyagi M
Laryngoscope; 2012 Oct; 122(10):2169-74. PubMed ID: 22786718
[TBL] [Abstract][Full Text] [Related]
10. Clinical and pathological characteristics of IgG4-related sclerosing sialadenitis.
Ohta N; Kurakami K; Ishida A; Furukawa T; Saito F; Kakehata S; Izuhara K
Laryngoscope; 2012 Mar; 122(3):572-7. PubMed ID: 22241660
[TBL] [Abstract][Full Text] [Related]
11. Use of immunohistochemistry for IgG4 in the distinction of autoimmune pancreatitis from peritumoral pancreatitis.
Dhall D; Suriawinata AA; Tang LH; Shia J; Klimstra DS
Hum Pathol; 2010 May; 41(5):643-52. PubMed ID: 20149413
[TBL] [Abstract][Full Text] [Related]
12. [IgG4-related sclerosing disease].
Kamisawa T; Zenimoto M; Obayashi T
Rinsho Byori; 2009 Nov; 57(11):1113-9. PubMed ID: 20030180
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin G4, autoimmune pancreatitis and pancreatic cancer.
Bojková M; Dítě P; Dvořáčková J; Novotný I; Floreánová K; Kianička B; Uvírová M; Martínek A
Dig Dis; 2015; 33(1):86-90. PubMed ID: 25531501
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical study of autoimmune pancreatitis using anti-IgG4 antibody and patients' sera.
Aoki S; Nakazawa T; Ohara H; Sano H; Nakao H; Joh T; Murase T; Eimoto T; Itoh M
Histopathology; 2005 Aug; 47(2):147-58. PubMed ID: 16045775
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin G4-related autoimmune pancreatitis and sialadenitis: A case report.
Fan RY; Sheng JQ
World J Gastroenterol; 2015 Aug; 21(31):9448-52. PubMed ID: 26309373
[TBL] [Abstract][Full Text] [Related]
16. IgG4+ to IgG+ plasma cells ratio of ampulla can help differentiate autoimmune pancreatitis from other "mass forming" pancreatic lesions.
Sepehr A; Mino-Kenudson M; Ogawa F; Brugge WR; Deshpande V; Lauwers GY
Am J Surg Pathol; 2008 Dec; 32(12):1770-9. PubMed ID: 18779730
[TBL] [Abstract][Full Text] [Related]
17. Elevation of serum IgG4 in Western patients with autoimmune sclerosing pancreatocholangitis: a word of caution.
Hochwald SN; Hemming AW; Draganov P; Vogel SB; Dixon LR; Grobmyer SR
Ann Surg Oncol; 2008 Apr; 15(4):1147-54. PubMed ID: 18219538
[TBL] [Abstract][Full Text] [Related]
18. [IgG4-related sclerosing disease, including its relation to carcinogenesis].
Kamisawa T; Sasaki T
Gan To Kagaku Ryoho; 2011 Mar; 38(3):347-52. PubMed ID: 21403435
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of extrapancreatic lesions in autoimmune pancreatitis.
Naitoh I; Nakazawa T; Ohara H; Ando T; Hayashi K; Tanaka H; Okumura F; Miyabe K; Yoshida M; Sano H; Takada H; Joh T
Pancreas; 2010 Jan; 39(1):e1-5. PubMed ID: 19924018
[TBL] [Abstract][Full Text] [Related]
20. Involvement of inducible costimulator- and interleukin 10-positive regulatory T cells in the development of IgG4-related autoimmune pancreatitis.
Kusuda T; Uchida K; Miyoshi H; Koyabu M; Satoi S; Takaoka M; Shikata N; Uemura Y; Okazaki K
Pancreas; 2011 Oct; 40(7):1120-30. PubMed ID: 21926547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
